These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 29246759)

  • 1. Metabolic Control of CD8
    Zhang L; Romero P
    Trends Mol Med; 2018 Jan; 24(1):30-48. PubMed ID: 29246759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation.
    Veliça P; Zech M; Henson S; Holler A; Manzo T; Pike R; Santos E Sousa P; Zhang L; Heinz N; Schiedlmeier B; Pule M; Stauss H; Chakraverty R
    Cancer Res; 2015 Jul; 75(13):2641-52. PubMed ID: 25904681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Control of Epigenetics and Its Role in CD8
    Yerinde C; Siegmund B; Glauben R; Weidinger C
    Front Immunol; 2019; 10():2718. PubMed ID: 31849941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinforce the antitumor activity of CD8
    Nabe S; Yamada T; Suzuki J; Toriyama K; Yasuoka T; Kuwahara M; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
    Cancer Sci; 2018 Dec; 109(12):3737-3750. PubMed ID: 30302856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.
    Chaoul N; Fayolle C; Desrues B; Oberkampf M; Tang A; Ladant D; Leclerc C
    Cancer Res; 2015 Aug; 75(16):3279-91. PubMed ID: 26122844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts of T cell metabolism as a target of immunotherapy.
    Chang CH; Pearce EL
    Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.
    Ghoneim HE; Zamora AE; Thomas PG; Youngblood BA
    Trends Mol Med; 2016 Dec; 22(12):1000-1011. PubMed ID: 27825667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic plasticity of T cell fate decision.
    Pan X; Wang J; Zhang L; Li G; Huang B
    Chin Med J (Engl); 2024 Apr; 137(7):762-775. PubMed ID: 38086394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-Targeted Attenuation of IL-2 Signaling in CD8
    Rajagopalan A; Berezhnoy A; Schrand B; Puplampu-Dove Y; Gilboa E
    Mol Ther; 2017 Jan; 25(1):54-61. PubMed ID: 28129128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Roles of CD8
    St Paul M; Ohashi PS
    Trends Cell Biol; 2020 Sep; 30(9):695-704. PubMed ID: 32624246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
    Pilipow K; Scamardella E; Lugli E
    Methods Enzymol; 2020; 631():137-158. PubMed ID: 31948545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity.
    Zhao H; Liu Y; Wang L; Jin G; Zhao X; Xu J; Zhang G; Ma Y; Yin N; Peng M
    Cell Rep; 2021 Dec; 37(10):110083. PubMed ID: 34879274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine uptake regulates CD8 T cell antitumor immunity.
    Di Biase S; Ma X; Wang X; Yu J; Wang YC; Smith DJ; Zhou Y; Li Z; Kim YJ; Clarke N; To A; Yang L
    J Exp Med; 2019 Dec; 216(12):2869-2882. PubMed ID: 31628186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
    Cheng H; Ma K; Zhang L; Li G
    Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunometabolism of CD8
    Shi H; Chen S; Chi H
    Trends Cancer; 2024 Jul; 10(7):610-626. PubMed ID: 38693002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
    Kishton RJ; Sukumar M; Restifo NP
    Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironment-driven metabolic adaptations guiding CD8
    Park J; Hsueh PC; Li Z; Ho PC
    Immunity; 2023 Jan; 56(1):32-42. PubMed ID: 36630916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.